Compare SUVEN LIFE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES PFIZER SUVEN LIFESCIENCES/
PFIZER
 
P/E (TTM) x 4.3 37.6 11.5% View Chart
P/BV x 0.6 6.3 10.0% View Chart
Dividend Yield % 3.6 0.5 673.0%  

Financials

 SUVEN LIFESCIENCES   PFIZER
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
PFIZER
Mar-19
SUVEN LIFESCIENCES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3383,840 8.8%   
Low Rs1692,080 8.1%   
Sales per share (Unadj.) Rs52.1455.0 11.5%  
Earnings per share (Unadj.) Rs6.893.8 7.3%  
Cash flow per share (Unadj.) Rs8.6109.4 7.8%  
Dividends per share (Unadj.) Rs1.5022.50 6.7%  
Dividend yield (eoy) %0.60.8 77.8%  
Book value per share (Unadj.) Rs65.3658.2 9.9%  
Shares outstanding (eoy) m127.2845.75 278.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.5 74.8%   
Avg P/E ratio x37.131.6 117.6%  
P/CF ratio (eoy) x29.627.1 109.3%  
Price / Book Value ratio x3.94.5 86.4%  
Dividend payout %22.024.0 91.5%   
Avg Mkt Cap Rs m32,272135,420 23.8%   
No. of employees `0001.12.6 41.1%   
Total wages/salary Rs m6613,238 20.4%   
Avg. sales/employee Rs Th6,132.27,911.4 77.5%   
Avg. wages/employee Rs Th611.11,230.9 49.6%   
Avg. net profit/employee Rs Th803.51,630.7 49.3%   
INCOME DATA
Net Sales Rs m6,63520,815 31.9%  
Other income Rs m2421,674 14.5%   
Total revenues Rs m6,87722,489 30.6%   
Gross profit Rs m1,6045,712 28.1%  
Depreciation Rs m221714 31.0%   
Interest Rs m3873 51.7%   
Profit before tax Rs m1,5876,599 24.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,309 31.1%   
Profit after tax Rs m8694,291 20.3%  
Gross profit margin %24.227.4 88.1%  
Effective tax rate %45.235.0 129.3%   
Net profit margin %13.120.6 63.6%  
BALANCE SHEET DATA
Current assets Rs m6,23227,167 22.9%   
Current liabilities Rs m1,4908,917 16.7%   
Net working cap to sales %71.587.7 81.5%  
Current ratio x4.23.0 137.3%  
Inventory Days Days8668 127.5%  
Debtors Days Days8330 274.4%  
Net fixed assets Rs m4,0438,862 45.6%   
Share capital Rs m127458 27.8%   
"Free" reserves Rs m8,18329,656 27.6%   
Net worth Rs m8,31030,113 27.6%   
Long term debt Rs m1825 71.2%   
Total assets Rs m10,38939,400 26.4%  
Interest coverage x43.191.5 47.1%   
Debt to equity ratio x00 258.0%  
Sales to assets ratio x0.60.5 120.9%   
Return on assets %8.711.1 78.8%  
Return on equity %10.514.2 73.4%  
Return on capital %19.522.1 88.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,622428 1,312.6%   
Fx outflow Rs m1,799786 228.8%   
Net fx Rs m3,822-358 -1,067.4%   
CASH FLOW
From Operations Rs m356978 36.3%  
From Investments Rs m-279351 -79.3%  
From Financial Activity Rs m-225-1,099 20.5%  
Net Cashflow Rs m-148231 -64.2%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.7 154.0%  
Shareholders   37,287 85,207 43.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views on News

PFIZER Share Price Up by 7%; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Jul 2, 2020 | Updated on Jul 2, 2020

PFIZER share price is trading up by 7% and its current market price is Rs 4,245. The BSE HEALTHCARE is up by 0.3%. The top gainers in the BSE HEALTHCARE Index is PFIZER (up 6.8%). The top losers are BLISS GVS PHARMA (down 0.1%) and PIRAMAL ENTERPRISES (down 0.1%).

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jul 2, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS